Evidence map›Paper›PMID 19843949›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17.

Victoria A Blaho, Matthew W Buczynski, Edward A Dennis, Charles R Brown

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Metabolites of prostaglandin synthases as potential biomarkers of Lyme disease severity and symptom resolution.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Redox Imbalance and Its Metabolic Consequences in Tick-Borne Diseases.Frontiers in cellular and infection microbiology · 2022
    Review
  6. Article
  7. Review
  8. Frontiers in immunology · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The role of eicosanoids in experimental Lyme arthritis.Frontiers in cellular and infection microbiology · 2014
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Victoria A BlahoDepartment of Veterinary Pathobiology, University of Missouri, Columbia, MO 65211, USA.
Matthew W Buczynski
Edward A Dennis
Charles R Brown
University of California San Diego · USUniversity of Missouri · US

Funding

STEROL LIPIDSU54GM069338 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DENNIS, EDWARD A · 2003 to 2013
$72.2M
Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
Eicosanoid regulation of experimental Lyme arthritisR01AR052748 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI BROWN, CHARLES R. · 2006 to 2010
$1.3M
NIAMS NIH HHS AR052748NIAMS NIH HHS R01 AR052748NIDDK NIH HHS DK07202NIDDK NIH HHS T32 DK007202NIGMS NIH HHS GM069338NIGMS NIH HHS U54 GM069338
6 · The paper itself

Abstract

The cyclooxygenase (COX) enzymes are known modulators of innate immune cell function; however, their contributions to adaptive immunity are relatively unknown. We investigated the roles of COX-1 and COX-2 in the humoral immune response to infection with the Lyme disease pathogen Borrelia burgdorferi. We report that in vitro, murine B cells constitutively expressed COX-1 and up-regulated expression of both COX-1 and COX-2 as well as their products PGE(2), PGF(2alpha), and thromboxane B(2) and their receptors following stimulation with B. burgdorferi or anti-CD40. In vitro inhibition of COX-1 and/or COX-2 in murine B cells resulted in decreased eicosanoid production and altered Ab production. Importantly, infection of mice lacking COX-1, but not COX-2, activity resulted in a defect in Ig class-switching and a lack of Borrelia-specific IgG production. This defect correlated with decreased germinal center formation and IL-6 and IL-17 production, and it could be partially recovered by restoration of IL-6, but fully recovered by IL-17. Furthermore, sera from COX-1 inhibitor-treated mice were dramatically less effective in killing B. burgdorferi, but borreliacidal activity was restored in COX-1 inhibitor-treated mice administered IL-17. We conclude that IL-17 plays a role in Ab production and Ig class-switching in response to infection and that COX-1 is a critical, previously unrecognized regulator of this response.

Indexed as

Immunoglobulin Class SwitchingAnimalsAntibodies, BacterialB-Lymphocyte SubsetsBorrelia burgdorferiCells, CulturedCyclooxygenase 1Cyclooxygenase 2FemaleGerminal CenterImmunoglobulin GImmunoglobulin MInterleukin-17Lyme DiseaseMembrane ProteinsMiceAntibodies, BacterialCyclooxygenase 1Cyclooxygenase 2Immunoglobulin GImmunoglobulin MInterleukin-17Membrane ProteinsPtgs1 protein, mousePtgs2 protein, mouse

Identifiers

PMID19843949
PMCPMC2857380
OpenAlexW2156554691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.